Negotiate lower prescription drug prices and cap insulin costs for more Americans.

John W. Mannion · New York · Democratic

policy impact 0.86 specificity 0.88 extraction confidence 98%

Contest this claim

Occurrences

Lowering Prescription Drug Prices: Negotiating lower drug prices and capping the cost of insulin for more Americans.

Commits to lowering drug costs and limiting insulin prices.

Healthcare - Mannion for New York
campaign · campaign_site · model gpt-5.4-mini

Evidence

Representative John W. Mannion represents New York’s 22nd Congressional District ... and served as the founding Chairman of the Senate Committee on Disabilities.

Confirms Mannion is a sitting federal representative and establishes the relevant office context for evaluating current-term policy actions.

unresolved same_term

About | Congressman John Mannion
secondary · model gpt-5.4-mini · confidence 94%

Contest this evidence item

The funding is in addition to the $358,000 in Community Project Funding Representative Mannion secured for Oneida Health in a partial funding bill that passed into law in November 2025.

Shows Mannion has recently secured federal health-related funding, but not the specific drug-price or insulin-cost outcome in the claim.

unresolved same_term

Representative John W. Mannion (NY-22) Advances Over $11 Million for NY-22 Public Safety, Lead Remediation, Clean Water, Workforce Training, and Advanced Research
primary · model gpt-5.4-mini · confidence 78%

Contest this evidence item

Together, Representative Mannion and Mayor Owens will use the State of the Union to deliver a message of government working for the people. They’ll highlight their shared commitment to lowering costs for families ...

Indicates Mannion is publicly emphasizing cost-lowering goals in his federal service, but it does not prove prescription-drug negotiation or insulin-cap enactment.

unresolved same_term

Representative John W. Mannion (NY-22) Announces Syracuse Mayor Sharon Owens as his Guest for the President's State of the Union Address
secondary · model gpt-5.4-mini · confidence 70%

Contest this evidence item

Medicare, Medicaid and disability insurance will be largely unaffected by a shutdown lasting less than three months. ... Medicare Issues ... 2026 Medicare Handbook ... Medicaid Issues ... Submit a Complaint with CMS.

Shows Mannion is actively directing constituents to Medicare and Medicaid resources, but there is no evidence here of action to negotiate lower prescription drug prices or cap insulin costs.

unresolved same_term

Government Shutdown FAQ | Congressman John Mannion
secondary · model gpt-5.4-mini · confidence 63%

Contest this evidence item

I joined a strong bipartisan majority in voting for the Fiscal Year 2026 National Defense Authorization Act ...

Confirms Mannion has participated in major floor votes during the current term; however, it contains no sign of legislation or a vote delivering the drug-price/insulin promise.

unresolved same_term

Statement from Representative John W. Mannion on National Defense Authorization Act
secondary · model gpt-5.4-mini · confidence 61%

Contest this evidence item

Oath of Office: Jan. 03, 2025 ... Representative John W. Mannion represents New York (NY) – 22nd, Democrat.

Confirms Mannion remains in active federal office during the lookback window; no direct evidence of the prescription-drug/insulin promise being delivered is shown on this page.

unresolved same_term

Office of the Clerk, U.S. House of Representatives
secondary · model gpt-5.4-mini · confidence 97%

Contest this evidence item

Learn more about legislation sponsored and co-sponsored by Congressman Mannion. ... Recent Votes ... 04/30/2026 | 155 | S.4465 | On Motion to Suspend the Rules and Pass | Nay ...

Provides a current official vote log, but the visible entry does not involve prescription-drug pricing or insulin caps, so it does not demonstrate delivery of the claim.

unresolved same_term

Votes and Legislation | Congressman John Mannion
secondary · model gpt-5.4-mini · confidence 74%

Contest this evidence item

Assessments

unresolved same_term

The available evidence confirms John W. Mannion has been serving in the House since January 2025 and is active on health and cost-related issues generally, but it does not show that he negotiated lower prescription drug prices, helped enact an insulin cap for more Americans, or materially advanced specific federal legislation accomplishing those outcomes. The cited pages are about office status, general votes, constituent resources, and unrelated funding, not the promised prescription-drug or insulin policy result. Because Mannion is still in office and the record provided does not establish either delivery or a serious documented attempt on this specific promise, the best judgment is unresolved rather than never.

provider openai · model gpt-5.4 · confidence 89%